PRODUCT USE ISSUE

This adverse event was reported 143352 times

These drugs are most commonly taken by patients reporting PRODUCT USE ISSUE:

# Drug Count
0 INFLIXIMAB 11312
1 DUPILUMAB 10785
2 POLYETHYLENE GLYCOL 3350 9405
3 METHOTREXATE SODIUM 8248
4 PREDNISONE 8183
5 METHOTREXATE 7307
6 DICLOFENAC SODIUM 6784
7 ACETAMINOPHEN 5642
8 CETIRIZINE HYDROCHLORIDE 5318
9 ADALIMUMAB 5316
See all common drugs associated with PRODUCT USE ISSUE

PRODUCT USE ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PSEUDOEPHEDRINE HYDROCHLORIDE 2265 0.4266
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 128 0.4000
2 PSEUDOEPHEDRINE HCL 2294 0.3651
3 CORTISONE ACETATE 2520 0.3364
4 CAFFEINE CITRATE 375 0.3032
5 DESOXIMETASONE 3177 0.2744
6 200 WET WIPES 128 0.2438
7 DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM 464 0.2365
8 CETIRIZINE HYDROCHLORIDE TABLETS 3052 0.1652
9 DICLOFENAC POTASSIUM TABLETS 531 0.1639
See all drugs enriched for association with PRODUCT USE ISSUE

PRODUCT USE ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Benzodiazepine Antagonist [EPC] 55 0.0863
1 Interleukin-4 Receptor alpha Antagonist [EPC] 10785 0.0624
2 Melanin Synthesis Inhibitor [EPC] 54 0.0589
3 Interleukin-12 Antagonist [EPC] 4401 0.0567
4 Osmotic Laxative [EPC] 10048 0.0563
5 Antirheumatic Agent [EPC] 4629 0.0524
6 Aminosalicylate [EPC] 5324 0.0511
7 Interleukin-6 Receptor Antagonist [EPC] 4803 0.0490
8 Polyene Antimicrobial [EPC] 12 0.0486
9 Methylating Agent [EPC] 36 0.0423
See all drug classes enriched for association with PRODUCT USE ISSUE